GI CONNECT has summarised the highlights of the recent ASCO and WCGIC 2018 meetings for you.
Oncology
GI CONNECT Update from ASCO and WCGIC 2018
Episode 2: Cancers of the upper GI tract
Publication Date
Sep 2021
Dr Joleen Hubbard is Deputy Director of Clinical Research and Academic Affairs for the Allina Health Cancer Institute in Minneapolis, Minnesota. She was previously Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota and haematology/oncology training at Mayo Clinic, Rochester, Minnesota. Dr Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network.
Assoc. Prof. Joleen Hubbard has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Advisory boards: Bayer, Merck, BeiGene, Incyte
Research funding to institution: Merck, Boston Biomedical, Treos Bio, Senhwa Pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Other episodes in this series
Episode 1: Lower GI cancer
GI CONNECT Update from ASCO and WCGIC 2018
Episode 2: Cancers of the upper GI tract Current EpisodeShare this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the expertsOther programmes of interest
Video
Oncology Hemato-oncology
Early relapsed/refractory multiple myeloma (RRMM): best practices in management
A 3-part video series on managing early RRMM from leading medical experts
Experts
Dr Elena Zamagni, Dr Fredrik Schjesvold, Dr Joseph Mikhael-
Downloadable
Resources -
4 MIN
-
Sep 2024
Other
Episode
2
of 2
Oncology
Optimising samples for biomarker testing in lung, prostate and gastric cancer
Recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Aug 2024
Publication
Oncology
Advancing HCC management in Asia: insights from patients and HCPs
Paper published in Journal of Gastrointestinal Cancer
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
15 MIN
-
Jul 2024
Other
Oncology
Come and visit us in Barcelona at ESMO 2024!
Get your free professional profile photos taken with us at Booth 507
-
1 MIN
-
Jul 2024
Micro learning
Oncology Endocrinology Rare diseases
Tools for optimising treatment & management of advanced NETs
Maximising outcomes for patients with advanced neuroendocrine tumours
Experts
Prof. Emily Bergsland, Prof. Louis de MestierEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jul 2024
Video
Oncology
The evolving role of liquid biopsy in biomarker testing
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Experts
Assoc. Prof. Umberto Malapelle-
Downloadable
Resources -
5 MIN
-
Jul 2024